Company
Biostar Pharmaceuticals, Inc. (0001418133)
Standardized SEC financial data for Biostar Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001418133 · Pharmaceutical Preparations.
Gross margin
38.4%
Operating margin
-149.5%
Net margin
-239.0%
Revenue growth (YoY)
-91.2%
Return on equity
-15.4%
Free cash flow
$4.9M
Current ratio
1.31×
EPS (diluted)
$-2.50
Ratios for fiscal year 2016, standardized from SEC filings.
Income statement
| USD | FY2016 |
|---|---|
| Revenue | $2.4M |
| Cost of revenue | $1.5M |
| Gross profit | $915K |
| R&D expense | $1.1M |
| SG&A expense | $2.4M |
| Operating income | -$3.6M |
Balance sheet
| USD | FY2016 |
|---|---|
| Cash & equivalents | $173K |
| Inventory | $167K |
| Total current assets | $7.4M |
| Property, plant & equipment | $5.9M |
| Total assets | $42.5M |
| Total current liabilities | $5.6M |
Cash flow
| USD | FY2016 |
|---|---|
| Operating cash flow | $4.9M |
| Capital expenditures | $1.2M |
| Free cash flow | $3.7M |
| Investing cash flow | -$6.4M |
| Financing cash flow | $1.4M |
| Dividends paid | $0 |
Get 0001418133 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001418133/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001418133/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"